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Abstract 
A recent report postulated that the mast cell population is a significant reservoir for per-
sistent HIV infection. Our study attempted to validate this hypothesis by quantitatively 
comparing the distribution of mast cells and cells expressing the HIV protein p24 in HIV in-
fected patients. Consecutive sections of paraffin-embedded human tissues from various tis-
sue sites were subjected to immunohistochemistry with monoclonal antibodies to mast cell 
tryptase, viral protein p24, and other molecules. The sub-cellular distribution of these 
molecules was examined, to determine whether immunoreactivities to these molecules 
would be co-localized within the same cells. Our study revealed that, in two immediate ad-
jacent sections immunostained for mast cell tryptase and p24, respectively, all or nearly all 
tryptase and p24 expressing cells were distributed at different areas. In the single section 
double immunostained for mast cell tryptase and p24, 5 (1.1%) of 460 large p24 expressing 
cell clusters encountered showed a single or few mast cells within or adjacent to p24 ex-
pressing cell clusters, but no distinct co-localization of these two proteins was observed. 
Similarly, no distinct co-localization was observed in any of over 500 isolated individual mast 
cells and p24 expressing cells. In contrast, macrophages were consistently intermixed with 
or adjacent to p24 expressing cells, and p24 immunostaining were seen in the cytoplasm of a 
subset of macrophages. These findings suggest that tissue mast cells do not show evidence 
for active virus replication by the techniques employed.   
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Introduction 
It is a commonly held belief that persistent HIV 
infection is maintained by a subset of latently infected, 
long-lived T and non-T cell populations [1-2]. Poten-
tial sanctuaries for the persistent HIV infection in-
clude natural killer cells, astrocytes, microglia, B cells, 
dendritic cells, macrophages, and memory T cells 
[3-7]. Macrophages and memory T cells are more 
commonly considered as the most significant stable 
reservoirs for persistent HIV infection because of their 
longevity, wide distribution, and the ability to harbor 
replication-components of the virus [3-7]. Unfortu-
nately, there is neither an established method to 
quantify the number of latently infected cells in HIV 
patients, nor is there a highly representative in vitro Int. J. Biol. Sci. 2009, 5 
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model that could be used to quantitatively monitor 
the entire process of HIV infection [8]. In addition, 
most studies have been preferentially focused on pe-
ripheral blood, tissue cultures and animal models, 
and have not looked at H&E stained sections of or-
gans from patients with HIV. Thus, the dynamics of 
HIV infection and the extent of contributions of each 
HIV reservoir to development and progression of HIV 
infection in different sites of human tissues remain 
elusive [8]. Furthermore, new types of cells are con-
tinually implicated as HIV reservoirs [9-10].   
 Based on results from studies in human tissue 
cultures, venous and cord blood, and placental tissues 
with immunophenotyping, image analysis, real-time 
PCR, and ELISA assay, Sundstrom et al have recently 
advanced a new hypothesis that human tissue mast 
cells are an inducible reservoir for persistent HIV in-
fection [11]. This hypothesis postulates that unlike 
other HIV vulnerable cell lineages, progenitor mast 
cells (prMCs) are susceptible to infection during a 
limited period of their ontogeny. After infection with 
HIV, prMCs lose the expression of viral chemokine 
coreceptors and develop into long-lived, latently in-
fected mature mast cells that are resistant to new HIV 
infection. In vivo recruitment of prMCs occurs in re-
sponse to tissue injury, growth, remodeling, allergic 
reactions, or inflammation, which allow HIV-infected 
prMCs to spread persistent HIV infection to different 
tissue sites [11]. 
 This hypothesis regarding the function of prMCs 
in HIV appears to be supported by some recent stud-
ies: (1) a previous study by a different group has 
shown that prMCs can be infected by HIV and retain 
virus with maturation in vitro [12], (2) increasing 
studies have shown that mast cells are capable of 
regulating inflammation, host defense, or innate im-
munity, and (3) the number and functions of mast 
cells change significantly following HIV infection 
[13-15]. This hypothesis, however, has not been vali-
dated in different tissue sites of HIV-infected indi-
viduals. Therefore, our study attempted to validate 
this hypothesis by statistically comparing the distri-
bution of mast cells and p24 expressing cells in dif-
ferent tissue sites of HIV infected patients.  
Materials and Methods 
Paraffin-embedded tissue blocks from different 
anatomic sites (lymph node, cervix, parotid glands, 
nasopharynx, and GI-tract) of 10 HIV infected pa-
tients were retrieved from the files of The Armed 
Forces Institute of Pathology with consent from the 
contributors. All patients were known to be 
HIV-infected and none had mast cell-related disease.  
Consecutive sections at 4-5um thickness were cut 
from each block and placed on positively-charged 
microscopic slides. The first and last sections from 
each case were subjected to H&E staining for mor-
phological classification. The remaining sections were 
used for immunohistochemical staining. A mouse 
monoclonal antibody against human HIV p24 capsid 
protein was purchased from Novocastra Laboratories, 
Ltd (Newcastle, UK). A mouse monoclonal antibody 
(clone: AA1) against human mast cell tryptase was 
purchased from Dako (Giostrup, Denmark). The cor-
responding secondary antibody, ABC detection kits, 
and substrate kits were obtained from Vector Labo-
ratories (Burlingame, CA). 
To assess potential co-localization (defined as the 
expression of two proteins within the same cell) of p24 
and mast cell tryptase, three technical approaches 
were used. First, sets of two immediate adjacent sec-
tions from each case were subjected to immunostain-
ing for p24 and mast cell tryptase, respectively, using 
our published protocols [16-17]. After immunostain-
ing, 5-7 identical areas at two different sections of the 
same case were photographed, and the cellular dis-
tribution of these two proteins in enlarged prints was 
examined, to determine whether immunoreactivities 
to these two proteins would be co-localized within the 
same cells. Second, a single section from each case 
was subjected to double immunohistochemistry for 
mast cell tryptase and p24, as previously described 
[16-17]. After immunostaining, all large p24 positive 
cell clusters (at least 10 p24 positive cells/per cluster) 
in each case were photographed, and the distribution 
of these two proteins in enlarged prints was exam-
ined, to determine whether they would be 
co-localized within the same cells. In addition, all 
isolated individual p24 or mast cell tryptase positive 
cells in each case were photographed, and the distri-
bution of these two proteins in enlarged prints was 
examined, to determine whether they would be 
co-localized within the same cells. Third, as previous 
studies have well documented that a subset of 
macrophages is a significant reservoir for latent HIV 
infection and replication, and that macrophages and 
mast cells share a similar mechanism of in vivo re-
cruitment [18-19], two adjacent sections from each 
case were double immunostained for p24 plus mast 
cell tryptase, and p24 plus macrophage 
(NCL-MACRO, Novocastra Laboratories, Ltd, New-
castle, UK), respectively. The distribution pattern of 
macrophages and mast cells relative to p24 positive 
cells were compared with special attention to p24 
immunostaining within mast cells or macrophages.  
To assess the specificity of the immunostaining, 
two technical approaches were utilized. First, differ-
ent negative controls were used, which included (1) Int. J. Biol. Sci. 2009, 5 
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the substitution of the primary antibody with the 
normal serum, (2) the omission of the secondary an-
tibody from the immunostaining sequence, (3) a series 
dilution of the primary antibodies, and (4) the inclu-
sion of non-HIV infected normal tissue sections from 
each site. Second, the procedure was repeated at least 
twice using the same protocol and under the same 
condition. Immunostained sections were independ-
ently evaluated by all investigators. A given cell was 
considered positive, if distinct (++ or more) immu-
noreactivity was consistently seen in its cytoplasm, 
whereas all the negative controls were devoid of im-
munoreactivities. 
Results  
All 10 cases showed p24 (+) cells and scattered 
mast cells or clusters of mast cells. The parotid tissues 
showed moderate reactive changes with increase 
leukocyte infiltration. All negative controls were de-
void of distinct immunoreactivities. The evaluations 
among investigators were consistent.   
Within lymph nodes, the p24 antibody showed a 
dendritic staining pattern and marked cells within 
follicular dendritic areas (surface staining presumed 
to be trapped virus rather than productive infection). 
In two immediate adjacent sections immunostained 
for mast cell tryptase and p24, respectively, mast cells 
and p24 expressing cells were differentially distrib-
uted. As shown in Fig 1, a vast majority of p24 ex-
pressing cells are arranged as densely packed clusters 
with different sizes and shapes, while a vast majority 
of mast cells are found scattered and individually 
distributed. Substantially fewer mast cells are found 
adjacent to, compared to those at a distance from, p24 
expressing cell clusters.  
 
1a 1b
1c 1d
 
Figure 1. Differential distribution of mast cells and p24 expressing cells in lymph nodes. Two immediate adjacent sections 
from HIV infected lymph nodes were immunostained for mast cell tryptase and p24, respectively. Circles identify p24 
expressing cell clusters. Arrows identify mast cells. Note that mast cells and p24 expressing cells are distributed at different 
sites, and no distinct co-localization of these two proteins is seen. 100X.  Int. J. Biol. Sci. 2009, 5 
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Figure 2. Differential distribution of mast cells and p24 positive cell clusters in different tissue sites. Sections from HIV 
infected GI tract (a-b), parotid glands (c-d), cervix (e-f), and lymph nodes (g-h) were double immunostained for mast cell 
tryptase (red) and p24 (brown). Circles identify p24 expressing cell clusters. Arrows identify mast cells. Note that mast cells 
and p24 expressing cells are distributed at different sites, and no distinct co-localization of these two proteins is seen. a, c & 
e: 100X. b, d & f: a higher magnification (300X) of a, c & e, respectively.  Int. J. Biol. Sci. 2009, 5 
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The distribution pattern of p24 expressing and 
mast cells in all other tissue sites, including cervix, 
parotid glands, nasopharynx, and GI-tract was very 
similar to that in lymph nodes. In sections double 
immunostained for mast cell tryptase and p24 with 
two differently colored substrates, 455 (98.9%) of the 
460 large p24 expressing cell clusters encountered had 
no immediately surrounding mast cells (Fig 2). Only 5 
(1.1%) of 460 p24 expressing cell clusters showed the 
distribution of mast cells within or adjacent to p24 
expressing cell clusters, whereas no distinct 
co-localization of these two proteins was observed 
(Table 1; Fig 2). Similarly, no distinct co-localization 
was seen among over 500 isolated individual mast or 
p24 expressing cells examined (Table 2; Fig 3).  
The distribution of macrophages sharply dif-
fered from that of mast cells in two aspects: 1) 
macrophages were consistently intermixed with or 
adjacent to p24 expressing cells, and 2) p24 immu-
nostaining were seen in the cytoplasm of a subset of 
macrophages (Fig 4).  
Table 1. Frequency of mast cell infiltration into HIV in-
fected cell clusters 
HIV (+) cell 
clusters  
With mast cell infiltra-
tion (%) 
Co-localization of p24 and 
tryptase 
 460   5 (1.1%)   0 
 
 
Table 2. Frequency of co-localization of isolated p24 (+) 
and mast cells 
Cell types  Cells counted  Co-localization of p24 and tryptase
 p24 (+) cells  50   0 
 Mast cells   500   0 
 
 
3a 3b
3c 3d
 
Figure 3. Differential distribution of isolated p24 expressing and mast cells. Sections from HIV infected lymph nodes were 
double immunostained for mast cell tryptase (red) and p24 (brown). Thin arrows identify p24 expressing cells. Thick arrows 
identify mast cells. Note that mast cells and p24 expressing cells are separately distributed, and no distinct co-localization of 
these two proteins is seen. 400X. Int. J. Biol. Sci. 2009, 5 
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Figure 4. Physical association between p24 expressing cells and macrophages. Sections from HIV infected lymph nodes 
were double immunostained for macrophages (red) and p24 (brown). Arrows identify p24 immunostaining in macrophages. 
Note that macrophages are intermixed or adjacent to p24 expressing cells, whereas areas surrounding p24 expressing cell 
clusters have no or a very few macrophages (a-b). In addition, distinct p24 immunostaining is seen in the cytoplasm of a 
subset of p24 expressing cells (c-d). a-b: 100X; c-d: 1000X. 
 
Discussion 
 It has been well documented that direct physical 
contact among different cell types is the primary 
mechanism for HIV infection and AIDS pathogenesis 
[21]. The spread of HIV infection from reservoirs to 
different tissue sites is likely to share the same 
mechanism for two main reasons: 1) in vivo recruit-
ment of prMCs occurs in response to tissue injury, 
growth, remodeling, allergic reactions, or inflamma-
tion; 2) several HIV susceptible tissue sites, including 
the lymph node, cervix, GI-tract, salivary glands, and 
male genital tract, normally harbor abundant prMCs 
[9-10, 22-24]. Although HIV infected prMCs may 
gradually lose the expression of viral chemokine 
coreceptors, the re-seeding or spread of the virus ap-
parently requires the re-synthesis of the viral proteins 
and replication of the archival clone of the virus in the 
reservoir. The reactivation of latent HIV infection in 
the reservoir could be triggered by a number of fac-
tors, including T-cell activation, herpes-virus infec-
tion, or antifungal agent amphotericin B [25-27]. Thus, 
it is likely that a significant number of latently in-
fected mast cells at the stage of reactivation will ex-
press both mast and viral specific proteins, or at least, 
they would be physically blended within or immedi-
ately adjacent to HIV infected cells in different tissue 
sites of HIV patients. 
In contrast to our speculation, our study reveals 
differential distribution of mast and HIV infected 
cells, and a separate localization of mast cell and viral 
specific proteins in all or nearly all the sites and cells 
observed. The most likely explanation for our findings 
is that these mast cells are not derived from HIV in-
fected circulating progenitors. In agreement with our 
speculation is the fact that previous studies have well 
documented that progenitor mast cells derived from 
undifferentiated bone marrow are susceptible to HIV 
infection for only a short period of time [12]. Thus, the 
establishment and number of HIV infected mature 
mast cells as a HIV reservoir will be largely depend-
ent on the active recruitment of the susceptible circu-
lating progenitors at the initial stage of HIV infection. 
In our cases, the number of the susceptible circulating Int. J. Biol. Sci. 2009, 5 
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progenitors might be very small, or no susceptible 
circulating progenitors were recruited at the initial 
stage of HIV infection. Alternatively, mast cells seen 
in our study might represent a latently HIV infected 
population that is not currently reactivated. In 
agreement with our speculation is that previous 
studies have documented that mature mast cells, 
unlike macrophages, no longer express a detectable 
level of viral chemokine coreceptors and may have 
become resistant to HIV infection [11-12]. The consis-
tent lack of mast cells in areas surrounding p24 ex-
pressing cells, which is in sharp contrast to macro-
phages that are consistently intermixed with or adja-
cent to p24 expressing cells, suggest that mast cells 
may even have the capability to repel the in vivo re-
cruitment into HIV infected sites.  
 In either case, our findings appear to have sig-
nificant scientific and clinical implications. If further 
studies are unable to detect viral genetic sequences in 
mast cells, a statement could be made that mast cells 
may not be a significant reservoir for persistent HIV 
infection. On the other hand, if integrated viral gene 
sequences are detectable, mast cells could be poten-
tially used as a unique model to study latent HIV in-
fection. Since HIV reservoirs are the primary source of 
persistent HIV infection and drug resistance, identi-
fication of the predominant reservoirs, and the spe-
cific contribution and interactions among different 
reservoirs may lead to more effective interventions, 
and consequently improve prognosis.  
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